News and Announcements
Systemate Collaborates with Northern NSW Waste Management Company
- Published February 10, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Systemate announces partnership to co-develop AI technologies which will automate recycled waste data collection. Northern NSW recycled waste management company Revolve Your World, has partnered with Systemate to utilise the no code data management system and develop custom data applications, to integrate directly within the waste processing facilities.
With a large R&D project on the horizon and currently enjoying significant growth, Revolve Your World is deploying into new regions . The partnership with Systemate enables smart, streamlined efficient data management in this recycled waste growth industry.
About The Company
Systemate is an automated, agile, go anywhere no-code SaaS platform for data management. With features including AI assisted app design, workflow automation, mobile offline mode and API’s to intergrade with 3rd parties or IoT we have an edge in this booming industry. We have built the platform, attracted a stellar team and have a recurring subscription revenue in the APAC market.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
